KOR

e-Article

OA03.02 Atezolizumab as 1L Therapy for Advanced NSCLC in PD-L1–Selected Patients: Updated ORR, PFS and OS Data from the BIRCH Study
Document Type
Abstract
Source
In Journal of Thoracic Oncology January 2017 12(1) Supplement:S251-S252
Subject
Language
ISSN
1556-0864